The Food and Drug Administration (FDA) may change the animal sedative Xylazine from its status as a dangerous drug that can be be sold over the counter by pharmacists to being a specially-controlled drug for sale only at hospitals and animal ...
This post is a mere snippet of world-wide industry news, sponsored by:
BizLocal.com
BizLocal is a web-property of Inspetta LLC, providing innovative web, software and marketing services to business. Call 800-785-2925 for more information.